Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FNWNH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,071
Award facts
- Contract value 100% obligated
- $38,071.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of OPDIVO 240 mg/24 mL vials. This firm fixed-price delivery order, valued at approximately $38.1K, represents a non-set-aside competitive award and is scheduled for completion by October 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and other military healthcare systems. The company has an established track record with the DLA Medical Supply Chain, delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains through competitively awarded contracts with firm fixed pricing. The OPDIVO supply under this delivery order supports the company's broader mission to provide specialized oncology medications and other critical pharmaceutical commodities to federal healthcare beneficiaries globally.
Quick answers
Who was awarded contract SPE2DB25FNWNH?
SPE2DB25FNWNH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNWNH worth?
The government has obligated $38,071 on SPE2DB25FNWNH.
Is contract SPE2DB25FNWNH an order under another contract?
Yes. SPE2DB25FNWNH is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWNH competed?
The extent of competition for SPE2DB25FNWNH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award